4-((2s)-2-((5-Isoquinolinylsulfonyl)Methylamino)-3-Oxo-3-(4-Phenyl-1-Piperazinyl)Propyl)Phenylisoquinolinesulfonicacid
4-[(2s)-2-[(5-Isoquinolinylsulfonyl)Methylamino]-3-Oxo-3-(4-Phenyl-1-Piperazinyl)Propyl] Phenyl Isoquinolinesulfonic Acid Ester
CAS: 127191-97-3
Molecular Formula: C38H35N5O6S2
4-((2s)-2-((5-Isoquinolinylsulfonyl)Methylamino)-3-Oxo-3-(4-Phenyl-1-Piperazinyl)Propyl)Phenylisoquinolinesulfonicacid - Names and Identifiers
4-((2s)-2-((5-Isoquinolinylsulfonyl)Methylamino)-3-Oxo-3-(4-Phenyl-1-Piperazinyl)Propyl)Phenylisoquinolinesulfonicacid - Physico-chemical Properties
| Molecular Formula | C38H35N5O6S2 |
| Molar Mass | 721.84 |
| Density | 1.388 |
| Melting Point | 92-94°C |
| Boling Point | 964.7±75.0 °C(Predicted) |
| Flash Point | 537.2°C |
| Solubility | 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: 0.93mg/mL |
| Vapor Presure | 0mmHg at 25°C |
| Appearance | solid |
| Color | white |
| pKa | 4.07±0.13(Predicted) |
| Storage Condition | -20°C |
| Refractive Index | 1.685 |
| Physical and Chemical Properties | Solubility: 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: 0.93 mg/mL storage conditions:? 20℃ WGK Germany:3 |
| In vitro study | KN-62 is a selective antagonist of Ca 2+ /calmodulin-dependent protein kinase II (CaMKII). KN-62 potently antagonizes ATP-stimulated Ba 2+ influx into fura-2 loaded human lymphocytes with an IC 50 of 12.7±1.5 nM (n=3) and complete inhibition of the flux at a concentration of 500 nM. Similarly, KN-62 inhibits ATP-stimulated ethidium + uptake, measured by time resolved flow cytometry, with an IC 50 of 13.1±2.6 nM (n=4) and complete inhibition of the flux at 500 nM. KN-62 is found to be a potent antagonist in a functional assay, inhibition of ATP-induced K + efflux in HEK293 cells expressing recombinant human P2X 7 receptors. In human leukemic B lymphocytes, KN-62 reduces the rate of permeability increase to larger permeant cations, like ethidium, induced by Bz-ATP with an IC 50 of 13.1 nM. KN-62 at a concentration of 3 µM has no effect on ATP-induced ethidium influx through the rat P2X 7 receptor, while the IC 50 at the human P2X 7 receptor is 0.1 µM. KN-62 has considerable selectivity for P2X 7 receptors within the P2 family. |
| In vivo study | The antidepressant-like behavior of ZnCl 2 (10 mg/kg, p.o.) (p<0.01) is prevented by CAMKII inhibitor KN-62 (1 μg/site, i.c.v.). The two-way ANOVA reveals a significantly main effect of KN-62 treatment [F(1,28)=27.47, p<0.01], no main effect of ZnCl 2 treatment [F(1,28)=0.84, p>0.05] and a significant effect of KN-62×ZnCl 2 treatment interaction [F(1,28)=22.57, p<0.01] to immobility time. As revealed by the post-hoc analysis, the anti-immobility effect of ZnCl 2 is completely prevented by treatment of animals with KN-62. No effect in locomotor activity in the open-field test is observed: (KN-62 treatment [F(1,24)=1.97, p>0.05], ZnCl 2 treatment [F(1,24)=3.99, p>0.05] and KN-62×ZnCl 2 treatment interaction [F(1,24)=0.61, p>0.05]). |
4-((2s)-2-((5-Isoquinolinylsulfonyl)Methylamino)-3-Oxo-3-(4-Phenyl-1-Piperazinyl)Propyl)Phenylisoquinolinesulfonicacid - Risk and Safety
| Safety Description | 24/25 - Avoid contact with skin and eyes. |
| WGK Germany | 3 |
| HS Code | 29339980 |
4-((2s)-2-((5-Isoquinolinylsulfonyl)Methylamino)-3-Oxo-3-(4-Phenyl-1-Piperazinyl)Propyl)Phenylisoquinolinesulfonicacid - Reference Information
| biological activity | KN-62 is a potent, selective calmodulin-dependent protein kinase II (CaMK-II) inhibitor, the IC50 is 0.9 μm, KN-62 is also a non-competitive P2X7 receptor antagonist, and the IC50 is approximately 15 nM. |
| Target | IC50: 0.9 μm (CaMK II), 15 nM (P2X 7 receptor, in HEK293 cells) |
Last Update：2024-04-09 20:52:54
